New drug trial aims to find safe dose for advanced breast cancer
Disease control
Recruiting now
This early-stage study is testing a new drug called OTS167PO in people with advanced breast cancer that has come back or spread. The main goal is to find the safest dose and understand side effects. About 70 women aged 18 and older will take part.
Phase: PHASE1 • Sponsor: OncoTherapy Science, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC